- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT05777343
Cvičení, PNE a kognitivní trénink u jedinců s chronickou bolestí dolní části zad
Vzdělávání, cvičení a kognitivní trénink u jedinců s idiopatickou chronickou bolestí dolní části zad o bolesti: Randomizovaná studie se třemi rameny
This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP).
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education (PNE) will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP).
It will have three arms of which will receive exercise, PNE and/or cognitive training for 8 weeks (Group I - exercise and PNE; Group II - exercise, PNE and cognitive training; Group III - cognitive training).
Participants will be assessed for pain characteristics, psychological, and cognitive aspects at baseline, post-intervention and at 3 months follow-up.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Aveiro District
-
Aveiro, Aveiro District, Portugalsko
- University of Aveiro
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- have chronic idiopathic LBP
- report pain intensity of at least 2 out of 10 on the Numeric Pain Rating Scale
- 18 to 64 years old
- Be able to read, write and speak Portuguese
- Asses to personal computer and internet for those receiving cognitive training
Exclusion Criteria:
- individuals receiving any chronic treatment for their pain
- symptoms of peripheral nervous system pathology (e.g., motor weakness and sensory disturbance);
- a diagnosis of an ongoing neurological disease with peripheral or central nervous system involvement or relevant sequela;
- having a diagnosis of ongoing psychiatric disease
- having relevant cognitive impairment as assessed by Montreal Cognitive Assessment (MoCA).
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Intervention 1
Participants will receive exercise, PNE and online cognitive training sessions. |
Cognitive training combined with the recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education). |
|
Aktivní komparátor: Intervention 2
Participants will receive exercise and pain neuroscience education (PNE). |
Recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education). |
|
Aktivní komparátor: Intervention 3
Participants will receive online cognitive training sessions. |
Online sessions of cognitive training. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Numeric Pain Rating Scale Numeric Pain Rating Scale
Časové okno: baseline
|
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable". |
baseline
|
|
Numeric Pain Rating Scale Numeric Pain Rating Scale
Časové okno: post-intervention - 8 weeks
|
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable". |
post-intervention - 8 weeks
|
|
Numeric Pain Rating Scale Numeric Pain Rating Scale
Časové okno: 3 months follow-up
|
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable". |
3 months follow-up
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Cognitive Function
Časové okno: baseline
|
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance. |
baseline
|
|
Cognitive Function
Časové okno: post-intervention - 8 weeks
|
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance. |
post-intervention - 8 weeks
|
|
Cognitive Function
Časové okno: 3 months follow-up.
|
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance. |
3 months follow-up.
|
|
Roland Morris disability questionnaire
Časové okno: baseline
|
The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability. |
baseline
|
|
Roland Morris disability questionnaire
Časové okno: post-intervention - 8 weeks
|
The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability. |
post-intervention - 8 weeks
|
|
Roland Morris disability questionnaire
Časové okno: 3 months follow-up
|
The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability. |
3 months follow-up
|
|
Central sensitization Inventory
Časové okno: baseline
|
The central sensitization inventory (CSI) assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points. |
baseline
|
|
Central sensitization Inventory
Časové okno: post-intervention - 8 weeks
|
The central sensitization inventory (CSI) assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points. |
post-intervention - 8 weeks
|
|
Central sensitization Inventory
Časové okno: 3 months follow-up
|
The central sensitization inventory (CSI)assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points. |
3 months follow-up
|
|
Hospital Anxiety and Depression Scale (HADS)
Časové okno: baseline
|
HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression. |
baseline
|
|
Hospital Anxiety and Depression Scale (HADS)
Časové okno: post-intervention - 8 weeks
|
HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression. |
post-intervention - 8 weeks
|
|
Hospital Anxiety and Depression Scale (HADS)
Časové okno: 3 months follow-up.
|
HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression. |
3 months follow-up.
|
|
TAMPA Scale of Kinesiophobia
Časové okno: baseline
|
The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement. |
baseline
|
|
TAMPA Scale of Kinesiophobia
Časové okno: post-intervention - 8 weeks
|
The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement. |
post-intervention - 8 weeks
|
|
TAMPA Scale of Kinesiophobia
Časové okno: 3 months follow-up.
|
The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement. |
3 months follow-up.
|
|
Pain Catastrophizing Scale
Časové okno: Baseline
|
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing. |
Baseline
|
|
Pain Catastrophizing Scale
Časové okno: post-intervention - 8 weeks
|
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing. |
post-intervention - 8 weeks
|
|
Pain Catastrophizing Scale
Časové okno: 3 months follow-up.
|
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing. |
3 months follow-up.
|
|
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Časové okno: baseline
|
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep. |
baseline
|
|
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Časové okno: post-intervention - 8 weeks
|
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep. |
post-intervention - 8 weeks
|
|
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Časové okno: 3 months follow-up.
|
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep. |
3 months follow-up.
|
|
Two-point discrimination
Časové okno: baseline
|
Two-point discrimination is used to assess cortical reorganization. |
baseline
|
|
Two-point discrimination
Časové okno: post-intervention - 8 weeks
|
Two-point discrimination is used to assess cortical reorganization. |
post-intervention - 8 weeks
|
|
Two-point discrimination
Časové okno: 3 months follow-up
|
Two-point discrimination is used to assess cortical reorganization. |
3 months follow-up
|
|
Patient's Global Impression of Change (PGIC)
Časové okno: post-intervention - 8 weeks
|
PGIC evaluates the perception of improvement associated with the intervention. Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition. |
post-intervention - 8 weeks
|
|
Patient's Global Impression of Change (PGIC)
Časové okno: 3 months follow-up.
|
PGIC evaluates the perception of improvement associated with the intervention. Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition. |
3 months follow-up.
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Ředitel studie: Anabela Silva, PhD, School of Health Sciences, University of Aveiro
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Chování
- Motorická aktivita
- Motorická aktivita
- Hnutí
- Muskuloskeletální fyziologické jevy
- Muskuloskeletální a nervové fyziologické jevy
- Terapeutika
- Péče o pacienty
- Zdravotní služby
- Zdravotnická zařízení pracovní síla a služby
- Rehabilitace
- Následná péče
- Kontinuita péče o pacienty
- Neurologická rehabilitace
- Cvičení
- Kognitivní trénink
Další identifikační čísla studie
- RCTCognitiveTraining
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Individual participant data are not publicly available due to ethical and privacy restrictions of the approved study protocol. An anonymized analysis dataset may be made available to qualified researchers upon reasonable request to the principal investigator and subject to approval by the Ethics and Deontology Council of the University of Aveiro.
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .